Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome

S Park, S Kim, B Kim, DS Kim, J Kim, Y Ahn, H Kim… - Nature Genetics, 2024 - nature.com
Metabolic syndrome (MetS) is a complex hereditary condition comprising various metabolic
traits as risk factors. Although the genetics of individual MetS components have been …

A proteogenomic view of Parkinson's disease causality and heterogeneity

S Kaiser, L Zhang, B Mollenhauer, J Jacob… - npj Parkinson's …, 2023 - nature.com
The pathogenesis and clinical heterogeneity of Parkinson's disease (PD) have been
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …

Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study

Y Chen, X Xu, L Wang, K Li, Y Sun, L **ao, J Dai… - …, 2022 - thelancet.com
Summary Background As aortic aneurysms (AAs) enlarge, they can become life-threatening
if left undiagnosed or neglected. At present, there is a lack of radical treatments for …

Harnessing the power of electronic health records and genomics for drug discovery

K Krebs, L Milani - Annual Review of Pharmacology and …, 2023 - annualreviews.org
A long-standing recognition that information from human genetics studies has the potential
to accelerate drug discovery has led to decades of research on how to leverage genetic and …

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson's disease

A Doostparast Torshizi, DT Truong, L Hou… - Nature …, 2024 - nature.com
Parkinson's disease is highly heterogeneous across disease symptoms, clinical
manifestations and progression trajectories, hampering the identification of therapeutic …

Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study

Y Cao, Y Yang, Q Hu, G Wei - Journal of translational medicine, 2023 - Springer
Introduction Rheumatoid arthritis (RA) is a chronic inflammatory illness that mostly affects the
joints of the hands and feet and can reduce life expectancy by an average of 3 to 10 years …

Expanding causal genes for Parkinson's disease via multi-omics analysis

XJ Gu, WM Su, M Dou, Z Jiang, QQ Duan… - npj Parkinson's …, 2023 - nature.com
Genome‑wide association studies (GWASs) have revealed numerous loci associated with
Parkinson's disease (PD). However, some potential causal/risk genes were still not revealed …

Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases

JV Lindbohm, N Mars, PN Sipilä, A Singh-Manoux… - Nature aging, 2022 - nature.com
Immune system and blood–brain barrier dysfunction are implicated in the development of
Alzheimer's and other dementia-causing diseases, but their causal role remains unknown …

Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine

X Sun, B Chen, Y Qi, M Wei, W Chen, X Wu… - The Journal of …, 2024 - Springer
Introduction Migraine, as a complex neurological disease, brings heavy burden to patients
and society. Despite the availability of established therapies, existing medications have …

Identification of potential causal genes for neurodegenerative diseases by mitochondria-related genome-wide Mendelian randomization

KF Yin, T Chen, XJ Gu, Z Jiang, WM Su, QQ Duan… - Molecular …, 2025 - Springer
Current research lacks comprehensive investigations into the potential causal link between
mitochondrial-related genes and the risk of neurodegenerative diseases (NDDs). We aimed …